EcoDrugPlus

Spleen Tyrosine Kinase

Ensembl ID : ENSIPUG00000024970
Gene Symbol: SYK
3 Cross references
200 Possible Orthologues:

Steroid-5-Alpha-Reductase, Alpha Polypeptide 2a

Ensembl ID : ENSIPUG00000006825
Gene Symbol: SRD5A2A
3 Cross references
208 Possible Orthologues:

Steroidogenic Cytochrome P450 17-Hydroxylase/lyase

Ensembl ID : ENSIPUG00000024439
Gene Symbol: CYP17
2 Cross references
210 Possible Orthologues:

Sterol O-Acyltransferase 1

Ensembl ID : ENSIPUG00000017255
Gene Symbol: SOAT1
3 Cross references
210 Possible Orthologues:

Tachykinin Receptor 1

Ensembl ID : ENSIPUG00000022448
Gene Symbol: TACR1
4 Cross references
193 Possible Orthologues:

Tachykinin Receptor 2

Ensembl ID : ENSIPUG00000015896
Gene Symbol: TACR2
3 Cross references
196 Possible Orthologues:

Tachykinin Receptor 3-Like

Ensembl ID : ENSIPUG00000017003
Gene Symbol: TACR3L
3 Cross references
243 Possible Orthologues:

Tachykinin Receptor 3a

Ensembl ID : ENSIPUG00000016246
Gene Symbol: TACR3A
3 Cross references
242 Possible Orthologues:

Telomerase Reverse Transcriptase

Ensembl ID : ENSIPUG00000022566
Gene Symbol: TERT
3 Cross references
189 Possible Orthologues:

Thromboxane A Synthase 1 (Platelet)

Ensembl ID : ENSIPUG00000014696
Gene Symbol: LOC108264404
3 Cross references
219 Possible Orthologues:

Thromboxane A2 Receptor

Ensembl ID : ENSIPUG00000024950
Gene Symbol: TBXA2R
3 Cross references
192 Possible Orthologues:

Thymidine Phosphorylase

Ensembl ID : ENSIPUG00000019794
Gene Symbol: LOC108279442
3 Cross references
174 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).